A fibre-optic probe which measures the amount of oxygen in tumours may help
doctors to reduce the side effects of chemotherapy. Tumours with high oxygen
levels are more susceptible to treatment, so researchers at Mount Vernon
Hospital, Middlesex, hope the probe will allow them to identify tumours which
require less chemotherapy and radiotherapy. The probe, called Oxylite, was
invented by Oxford Optronix. Its clinical development is being funded by the
Cancer Research Fund.
More from New Scientist
Explore the latest news, articles and features
Popular articles
Trending New Scientist articles
1
If you aren't terrified by this heatwave, you should be
2
Woman with Alzheimer's starts conversing again after taking psilocybin
3
The race to understand how and when Thwaites glacier will collapse
4
Where, when and how to watch the 2026 solar eclipse
5
Europe’s heatwave is the hottest and most humid ever
6
Faecal transplant makes the brains of old mice act young again
7
We’ve uncovered a master gene that switches on human development
8
How menopause radically changes the brain – and what happens after
9
Our verdict on The Selfish Gene: An unpopular piece of popular science
10
Lost books by ancient philosophers recovered from 'unreadable' scrolls
